Evaluation of Dentin Hypersensitivity Using Glass Ionomer Cements

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-04-02

Study Completion Date

2015-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this randomized, double-blind, split-mouth clinical trial is to evaluate and compare the desensitizing efficacies of the resin-modified glass ionomer cement ClinproTM XT (3M ESPE, Minnesota, USA) and the conventional glass ionomer cement Vidrion R (SS White, Gloucester, UK) at 2-year follow-up.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Clinical Study to Evaluate the Anti-Sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers

NCT06354270

Dentin Sensitivity

COMPLETED NA

A Clinical Study to Compare Professional Treatments for Dentinal Hypersensitivity

NCT03405259

Dentinal Hypersensitivity

COMPLETED NA

Dentinal Hypersensitivity Reduction

NCT06244290

Dentinal Hypersensitivity

COMPLETED PHASE3

Assessment of the Efficacy of an Experimental Occlusion Technology Dentifrice in Dentinal Hypersensitivity

NCT02861664

Dentin Sensitivity

COMPLETED NA

The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity (DH)

NCT02924350

Dentin Sensitivity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects will require to have at least two teeth in different hemiarchs with dentin hypersensitivity. Teeth will be randomized into 2 groups, receiving either Clinpro XT or the conventional glass ionomer cement Vidrion R. Prior to the desensitizing treatment (baseline), painful symptoms will be assessed by tactile and air blast tests using the Visual Analogue Scale (VAS). Treatment evaluations will be conducted up to 2-year post-treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dentin Hypersensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Clinpro XT (3M ESPE, Minnesota, USA)

Resin-modified glass ionomer cement

Group Type EXPERIMENTAL

Resin-modified glass ionomer cement Clinpro XT

Intervention Type DRUG

Clinpro XT (3M ESPE, Minnesota, USA)

Vidrion R (SS White, Gloucester, UK)

Conventional glass ionomer cement

Group Type ACTIVE_COMPARATOR

Glass Ionomer cement Vidrion R

Intervention Type DRUG

Vidrion R (SS White, Gloucester, UK)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Resin-modified glass ionomer cement Clinpro XT

Clinpro XT (3M ESPE, Minnesota, USA)

Intervention Type DRUG

Glass Ionomer cement Vidrion R

Vidrion R (SS White, Gloucester, UK)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Clinpro XT (3M Espe, USA) Vidrion R (SS White, Gloucester, UK)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female subjects between 18 and 70 years old
* At least 2 teeth with dentin hypersensitivity in two different hemiarchs
* Dental elements with hypersensitivity without any pulp alteration
* People who are not taking any medication and women who are not pregnant
* Patients without eating disorders or very acidic diets.

Exclusion Criteria

* Teeth with hypersensitivity that presented extensive or unsatisfactory restorations, fractures, periodontal alterations, caries lesions, orthodontic brackets, endodontic treatments, pulp alterations.
* Subjects who received any desensitizing therapy during the last 3 months
* Subjects being under analgesics/anti-inflammatory drugs at the time of the study
* Teeth with hypersensitivity and non-carious cervical lesions

Minimum Eligible Age

28 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes